Taro and NextWave Announce Agreement to Co-Promote OVIDE in the United States
July 31, 2008 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y. and VERNON HILLS, Ill., July 31, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") (Pink Sheets:TAROF) and NextWave Pharmaceuticals, Inc....
Taro Updates Shareholders On Financial Turnaround; Projects Significant Growth in Net Sales in 2008; Reaffirms Board's Recommendation Not to Tender Shares
July 28, 2008 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 28, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) today announced that it is sending a letter to its shareholders...
Taro Provides Preliminary First Half 2008 Financial Results
July 23, 2008 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 23, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) today provided information on its financial performance for the first...
Taro Board Concludes That Sun Tender Offer is Financially Inadequate, is a 'Sham' Offer and Violates Israeli Law
July 10, 2008 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 10, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) said today that its Board of Directors (with Drs. Barrie Levitt and...
Taro Board of Directors to Evaluate Unsolicited Tender Offer From Sun Pharmaceutical Industries Ltd.
June 30, 2008 17:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., June 30, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") (Pink Sheets:TAROF) said today that it would have no formal comment on the unsolicited...
Taro Receives Final FDA Approval for Rx Cetirizine Hydrochloride Syrup ANDA
June 23, 2008 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., June 23, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (Pink Sheets:TAROF) ("Taro", the "Company") reported today that it has received final approval from the U.S. Food...
Taro Sends Letter to Update Shareholders On Latest Developments Regarding the Terminated Sun Merger Agreement
June 19, 2008 07:10 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., June 19, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (Pink Sheets:TAROF) ("Taro" or the "Company") today announced that it is sending a letter to its shareholders...
Taro Terminates Merger Agreement With Sun Pharmaceutical Industries Ltd.
May 28, 2008 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
Taro Board Unanimously Rejects as Inadequate Sun's Revised
Offer of $10.25 Per Share
Significant Turnaround in Taro's Operating Performance;
Board...
Taro Reaches Agreement in Principle to Settle Securities Lawsuit
April 28, 2008 17:32 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 28, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) announced today that the parties in the purported securities class...
Taro Receives Final FDA Approval for Cetirizine Hydrochloride Oral Solution ANDA
April 22, 2008 11:16 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 22, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (Pink Sheets:TAROF) ("Taro", the "Company") reported today that it has received final approval from the U.S....